Pharma

From Scientific Excellence to Industrial Implementation

China’s Biopharmaceutical and Medtech Sector in 2026

Beyond Open Innovation: How to Make Pharma–Biotech Collab Work at Scale

Pharma is turning to open-innovation platforms like Bayer Co.Lab to speed science to clinic. CHEManager’s Christene Smith talks to Ruth Shah about the model and its value for start-ups and pharma.

Beyond Cost: What Manufacturers Look for in Investment Locations

Since COVID, pharma manufacturers have shifted from lean, centralized supply chains toward regionalized hubs — balancing cost, flexibility, and geopolitical security to build resilience against future economic shocks.

The Search Function: What AI Can't Replace in Biopharma Innovation

In AI-driven biopharma R&D, success means spotting outside innovation. CSL's Nishtha Jain on building AI platforms for external innovation, keeping human judgment central, and evolving leadership amid AI and ethics.

Lilly Breaks Ground on $6.5 Billion Houston Manufacturing Plant

Eli Lilly broke ground on a $6.5 billion Houston plant that will make Foundayo (orforglipron) and other medicines, creating over 600 jobs as part of its $50 billion push to reshore US drug manufacturing.

Prange Group Sells Remaining Shares in Adragos Pharma

German CDMO Prange has sold all remaining shares in Adragos Pharma to FSN Capital.

CDMOs/CMOs: The Key Moves in 2026

What have been key moves—capacity additions and acquisitions by CDMOs of drug substances (small molecules and biologics) thus far in 2026? A roundup of key developments.

Hovione Opens New Facility, Doubling US Spray Drying Capacity

Milestone completes a $100 million investment cycle in New Jersey and supports Hovione’s long-term vision for a next-generation pharmaceutical development and manufacturing hub.

Aseptic processing by design: The flexible and efficient use of RABS and Isolators

Explore how the flexible and efficient use of RABS and Isolators combined with operational expertise can address the challenges of aseptic processing.

Novo Nordisk and Anthropic Will Collaborate on Drug Discovery with Claude

PharmaBlock Inaugurates its New OPC R&D Center in Nanjing, China

PharmaBlock Sciences officially inaugurated its new OPC (Oligonucleotides, Peptides, and Conjugates) R&D Center in Nanjing, China.

DFE Pharma’s CM Platform accelerates the path from CM adoption to optimized performance

Navigate complex CM decisions with the right excipients, practical testing access and process understanding.

How Pharmaceutical Logistics Comes Together

Europe-wide 360° contract logistics for the pharmaceutical and healthcare industries are becoming even smoother—thanks to the new developments presented at CPHI in Milan.

CordenPharma Invests €80 Million to Expand Sterile Injectable Capacity

CordenPharma is investing €80 million at its Caponago, Italy, site, adding a new facility and fill-finish lines to lift sterile injectable capacity to 500 million units/year, backed by shareholder Astorg.

Lonza Announces Addition of Commercial Spray-Drying Facility at Bend Site

The investment will reinforce the Bend site as a center of excellence for particle engineering and bioavailability enhancement and create a global manufacturing hub for commercial spray-drying.

Clarity, Quality and Efficiency

Unveiled in April 2026, Brenntag's biopharma brand, Byphar, is aimed at companies in the biopharmaceutical industry. Joakim Rehné, President of Brenntag Pharma EMEA, explains the strategy behind the new brand.

Hovione Names Stefan Doboczky New CEO

Chairman of the Board of Directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027.

Northway Biotech Opens €61 Million Cell Therapy and Personalized Medicine CDMO

Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines.

Beyond the Catalog: Enamine's Journey to Global Drug Discovery Partner

In 2026, Enamine celebrates 35 years — from a small grant-funded Kyiv lab to a global partner with 3,000+ people across six countries.

Samsung Biologics Launches CHF 1.46 Billion Tender Offer for PolyPeptide

Samsung Biologics has published its formal offer prospectus to acquire PolyPeptide, deepening its push into peptide manufacturing as CDMOs race to expand capacity for GLP-1 and other peptide-based drugs.

Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity

New GMP (Good Manufacturing Practice) facility to meet increasing demand for lipid nanoparticle (LNP) development and clinical drug product manufacturing.

Wiley Launches Its First Spectral Analysis API Portfolio

New APIs extend Wiley's gold-standard spectral data and analytical intelligence directly into lab, vendor, and platform workflows.

Hovione Completes €40 Million Expansion of Loures Tablet Manufacturing Center

Expansion strengthens integrated manufacture of amorphous solid dispersions (ASDs) by spray drying and tableting at a single site, accelerating development and simplifying supply.

Piramal Pharma Acquires Yapan Bio

Piramal Pharma strengthens its biologics CDMO business, converting Yapan Bio from associate company to subsidiary and expanding vaccine and biologics manufacturing capabilities.

Cancer Vaccines Get Their First Real Win

The first personalized mRNA cancer therapy to beat the standard of care is now headed for regulators.

Modular Automation Moves from Vision to GMP Reality

A pharma project demonstrates how MTP can accelerate integration while reducing validation effort.

Eurofins CDMO Alphora Expands Capacity and HPAPI Capabilities

Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.

CDMO Live Americas

CDMO Live Americas is where external manufacturing partnerships are made.

Novo Nordisk Partners with Amazon to Boost Drug Discovery

Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.

Beacons of the Start-up Scene, Part 9: Biovox

Biovox develops bioplastic compounds that offer features such as inherent antimicrobial properties. At the same time, they are environmentally friendly.

Cambrex Milan Constructs New $30 Million R&D Facility; Celebrates 80th Anniversary

CDMO Cambrex started construction on a new R&D facility at its Milan, Italy site. The $30 million investment adds advanced analytical development and process R&D capabilities.

Bristol Myers Squibb Invests $2.3 Billion in Houston Campus

The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.

Mabion and KriSan Biotech Launch Partnership for Next-Gen ADCs

The partners will combine their unique capabilities to jointly develop, offer, and deliver integrated services in the Antibody-Drug Conjugates (ADC) segment for the global pharmaceutical and biotechnology industries.

Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development

Agreement advances new therapies through Engitix’s unique focus on the extracellular matrix (ECM).

Brenntag Pharma Enters into a Strategic Partnership with Evonik

An exclusive distribution agreement for Evonik Rexim amino acids strengthens Brenntag's role in the biopharma and API markets.